Fintel reports that on December 11, 2024, Wells Fargo upgraded their outlook for Merit Medical Systems (NasdaqGS:MMSI) from Equal-Weight to Overweight.
Analyst Price Forecast Suggests 6.44% Upside
As of December 3, 2024, the average one-year price target for Merit Medical Systems is $112.29/share. The forecasts range from a low of $104.03 to a high of $131.25. The average price target represents an increase of 6.44% from its latest reported closing price of $105.50 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Merit Medical Systems is 1,285MM, a decrease of 3.08%. The projected annual non-GAAP EPS is 3.18.
What is the Fund Sentiment?
There are 767 funds or institutions reporting positions in Merit Medical Systems. This is an increase of 76 owner(s) or 11.00% in the last quarter. Average portfolio weight of all funds dedicated to MMSI is 0.29%, an increase of 1.00%. Total shares owned by institutions increased in the last three months by 7.00% to 79,038K shares. 
The put/call ratio of MMSI is 0.03, indicating a bullish outlook.
What are Other Shareholders Doing?
IJR - iShares Core S&P Small-Cap ETF holds 3,699K shares representing 6.35% ownership of the company. In its prior filing, the firm reported owning 3,758K shares , representing a decrease of 1.59%. The firm increased its portfolio allocation in MMSI by 1.58% over the last quarter.
Conestoga Capital Advisors holds 2,289K shares representing 3.93% ownership of the company. In its prior filing, the firm reported owning 2,250K shares , representing an increase of 1.69%. The firm increased its portfolio allocation in MMSI by 5.86% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 1,750K shares representing 3.00% ownership of the company. In its prior filing, the firm reported owning 1,747K shares , representing an increase of 0.16%. The firm increased its portfolio allocation in MMSI by 8.17% over the last quarter.
Fuller & Thaler Asset Management holds 1,597K shares representing 2.74% ownership of the company. In its prior filing, the firm reported owning 1,546K shares , representing an increase of 3.17%. The firm increased its portfolio allocation in MMSI by 8.88% over the last quarter.
Macquarie Group holds 1,586K shares representing 2.72% ownership of the company. In its prior filing, the firm reported owning 1,746K shares , representing a decrease of 10.07%. The firm decreased its portfolio allocation in MMSI by 27.93% over the last quarter.
Merit Medical Systems Background Information
(This description is provided by the company.)
Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
